p63 is a prostate basal cell marker and is required for prostate development.

The p53 homologue p63 encodes for different isotypes able to either transactivate p53 reporter genes (TAp63) or act as p53-dominant-negatives (DeltaNp63). p63 is expressed in the basal cells of many epithelial organs and its germline inactivation in the mouse results in agenesis of organs such as skin appendages and the breast. Here, we show that prostate basal cells, but not secretory or neuroendocrine cells, express p63. In addition, prostate basal cells in culture predominantly express the DeltaNp63alpha isotype. In contrast, p63 protein is not detected in human prostate adenocarcinomas. Finally, and most importantly, p63(-/-) mice do not develop the prostate. These results indicate that p63 is required for prostate development and support the hypothesis that basal cells represent and/or include prostate stem cells. Furthermore, our results show that p63 immunohistochemistry may be a valuable tool in the differential diagnosis of benign versus malignant prostatic lesions.

[1]  G van den Engh,et al.  Cell-cell interaction in prostate gene regulation and cytodifferentiation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[2]  M. Harper,et al.  Studies on the proliferation, secretory activities, and epidermal growth factor receptor expression in benign prostatic hyperplasia explant cultures , 1992, The Prostate.

[3]  J. Schalken,et al.  Differential expression of keratins in the basal and luminal compartments of rat prostatic epithelium during degeneration and regeneration , 1988, The Prostate.

[4]  F. McKeon,et al.  Association of p63 with proliferative potential in normal and neoplastic human keratinocytes. , 1999, The Journal of investigative dermatology.

[5]  J. Jen,et al.  A new human p53 homologue , 1998, Nature Medicine.

[6]  C. Azzoli,et al.  p53-mediated transcriptional activity increases in differentiating epidermal keratinocytes in association with decreased p53 protein. , 1995, Oncogene.

[7]  H. Vogel,et al.  p63 is a p53 homologue required for limb and epidermal morphogenesis , 1999, Nature.

[8]  M. Loda,et al.  Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[9]  Rainer M. Bohle,et al.  Real-time quantitative RT–PCR after laser-assisted cell picking , 1998, Nature Medicine.

[10]  P. Troncoso,et al.  c-met proto-oncogene expression in benign and malignant human prostate tissues. , 1995, The Journal of urology.

[11]  S. J. Higgins,et al.  The endocrinology and developmental biology of the prostate. , 1987, Endocrine reviews.

[12]  Chikashi Ishioka,et al.  Cloning and functional analysis of human p51, which structurally and functionally resembles p53 , 1998, Nature Medicine.

[13]  P. Beer-Romero,et al.  Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. , 1995, Science.

[14]  Christopher T Denny,et al.  Leukemia and the disruption of normal hematopoiesis , 1991, Cell.

[15]  Christopher P. Crum,et al.  p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development , 1999, Nature.

[16]  M. Loda,et al.  Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer , 2000, Oncogene.

[17]  A. Collins,et al.  Basal cells are progenitors of luminal cells in primary cultures of differentiating human prostatic epithelium , 1998, The Prostate.

[18]  R. Santen,et al.  Response of glandular versus basal rat ventral prostatic epithelial cells to androgen withdrawal and replacement , 1987, The Prostate.

[19]  E. Bengal,et al.  p53 protein is activated during muscle differentiation and participates with MyoD in the transcription of muscle creatine kinase gene , 1998, Oncogene.

[20]  D. Chopin,et al.  Detection of the apoptosis-suppressing oncoprotein bc1-2 in hormone-refractory human prostate cancers. , 1993, The American journal of pathology.

[21]  R. Nagle,et al.  Cytokeratin characterization of human prostatic carcinoma and its derived cell lines. , 1987, Cancer research.

[22]  A. Yang,et al.  p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. , 1998, Molecular cell.

[23]  H. Kato,et al.  A second p53-related protein, p73L, with high homology to p73. , 1998, Biochemical and biophysical research communications.

[24]  G. Evans,et al.  Cell proliferation studies in the rat prostate: II. The effects of castration and androgen‐induced regeneration upon basal and secretory cell proliferation , 1987, The Prostate.

[25]  M. Campbell,et al.  Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. , 1992, Cancer research.